Table 2.
Sample Characteristics Before and After Matching for 2019
| |
2019 Before matching |
2019 After matching |
||||||
|---|---|---|---|---|---|---|---|---|
| |
WMHP users group |
Comparison group |
|
|
WMHP users group |
Comparison group |
|
|
| Variable | n = 4182 |
n = 41,437 |
|
|
n = 3883 |
n = 3883 |
|
|
| Mean or % | Mean or % | Standardized differences | P | Mean or % | Mean or % | Standardized differences | P | |
| Age | 31.36 | 27.21 | 0.342 | <0.001 | 31.11 | 31.81 | −0.088 | <0.001 |
| Adult (%) | 93.6% | 67.6% | 0.698 | <0.001 | 93.6% | 91.5% | 0.081 | <0.001 |
| Female (%) | 56.0% | 43.0% | 0.261 | <0.001 | 55.7% | 53.4% | 0.046 | 0.047 |
| MSA 1 | 30.9% | 26.6% | 0.094 | <0.001 | 31.4% | 28.8% | 0.056 | 0.013 |
| MSA 2 | 14.0% | 14.9% | −0.024 | 0.138 | 14.2% | 16.1% | −0.054 | 0.018 |
| MSA 3 | 10.2% | 8.5% | 0.059 | <0.001 | 9.7% | 11.0% | −0.043 | 0.057 |
| MSA 4 | 5.9% | 3.3% | 0.123 | <0.001 | 5.9% | 5.0% | 0.041 | 0.072 |
| MSA 5 | 5.6% | 2.5% | 0.155 | <0.001 | 5.2% | 3.2% | 0.096 | <0.001 |
| All other MSAs | 33.5% | 44.2% | −0.221 | <0.001 | 33.6% | 35.8% | −0.046 | 0.043 |
| Mood disorders (%) | 33.9% | 3.4% | 0.849 | <0.001 | 33.8% | 33.8% | 0.000 | 1.000 |
| Anxiety (%) | 67.0% | 4.4% | 1.726 | <0.001 | 66.6% | 54.2% | 0.254 | <0.001 |
| Adjustment disorders (%) | 35.4% | 2.0% | 0.949 | <0.001 | 35.6% | 25.5% | 0.219 | <0.001 |
| Attention-deficit disorders (%) | 5.0% | 1.7% | 0.183 | <0.001 | 4.0% | 4.0% | 0.000 | 1.000 |
| Alcohol/substance disorders (%) | 1.8% | 0.5% | 0.120 | <0.001 | 1.1% | 1.1% | 0.000 | 1.000 |
| Asthma (%) | 2.7% | 2.4% | 0.020 | 0.237 | 1.9% | 1.9% | 0.000 | 1.000 |
| Blood cell disease (%) | 0.4% | 0.4% | 0.005 | 0.859 | 0.1% | 0.1% | 0.000 | 1.000 |
| Cancer (%) | 0.6% | 0.6% | −0.005 | 0.823 | 0.2% | 0.2% | 0.000 | 1.000 |
| Secondary cancer (%) | 0.1% | 0.0% | 0.025 | 0.126 | 0.0% | 0.0% | 0.000 | 1.000 |
| Cardiovascular (%) | 3.5% | 2.6% | 0.050 | 0.001 | 2.2% | 2.2% | 0.000 | 1.000 |
| Lower back/disk diseases (%) | 18.6% | 9.2% | 0.276 | <0.001 | 17.2% | 17.2% | 0.000 | 1.000 |
| Diabetes (%) | 0.9% | 0.9% | −0.004 | 0.865 | 0.5% | 0.5% | 0.000 | 1.000 |
| Diabetes with complications (%) | 0.9% | 0.7% | 0.026 | 0.108 | 0.4% | 0.4% | 0.000 | 1.000 |
| Esophageal/upper GI diseases (%) | 2.7% | 1.4% | 0.093 | <0.001 | 1.6% | 1.6% | 0.000 | 1.000 |
| Hypertension (%) | 2.3% | 1.8% | 0.032 | 0.044 | 2.0% | 2.1% | −0.009 | 0.749 |
| Metabolic disorders (%) | 3.5% | 2.5% | 0.054 | <0.001 | 2.4% | 2.4% | 0.000 | 1.000 |
| Migraine/headache (%) | 5.3% | 2.6% | 0.140 | <0.001 | 3.9% | 3.9% | 0.000 | 1.000 |
| Multiple sclerosis (%) | 0.2% | 0.1% | 0.027 | 0.081 | 0.0% | 0.0% | 0.000 | 1.000 |
| Neurological disorders (%) | 4.7% | 3.1% | 0.082 | <0.001 | 2.9% | 2.9% | 0.000 | 1.000 |
| Osteoarthritis (%) | 0.6% | 0.6% | −0.004 | 0.882 | 0.3% | 0.3% | 0.000 | 1.000 |
| Pregnancy and labor (%) | 3.6% | 3.0% | 0.030 | 0.061 | 3.3% | 3.3% | 0.000 | 1.000 |
| Rheumatoid arthritis (%) | 0.2% | 0.2% | −0.008 | 0.747 | 0.0% | 0.0% | 0.000 | 1.000 |
GI, gastrointestinal; MSA, metropolitan statistical area; WMHP, workforce mental health program.